
Biden's FTC took on big tech, big pharma and more. What antitrust legacy will Biden leave behind?
On Point with Meghna Chakrabarti
00:00
Evaluating Antitrust Actions and Their Philosophical Roots
This chapter explores the philosophical and practical implications of large company efficiencies versus the risks associated with their growth, referencing failures like UnitedHealth. It also examines the Biden administration's antitrust strategies, including the formation of the White House Competition Council, and the challenges in achieving comprehensive competition policy.
Play episode from 28:00
Transcript


